NEW YORK, March 18 - (GenomeWeb News) - MWG Biotech said today that it was successful in opposing a European patent held by Applera over a patent for nucleic acid amplification.
The company, based in Ebersberg, Germany, said the European Patent Office revoked Applera's European Patent No. 236 069 B1, entitled "Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps," after MWG and others had opposed the patent.
This decision, the company said, is final. "There are no further judicial remedies," MWG said in a statement.
Applera had not issued any public statement on this matter.